{"id":2468,"date":"2020-11-16T08:32:54","date_gmt":"2020-11-16T07:32:54","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=2468"},"modified":"2020-11-16T08:32:54","modified_gmt":"2020-11-16T07:32:54","slug":"glomerulonefritis-covid-19-y-h12o","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2020\/11\/16\/glomerulonefritis-covid-19-y-h12o\/","title":{"rendered":"Glomerulonefritis, COVID-19 y H12O"},"content":{"rendered":"<p data-adtags-visited=\"true\">Ante el desconocimiento del impacto del SARS-COV-2 en pacientes con glomerulonefritis inmunomediadas, que a menudo se suelen someter a tratamientos inmunosupresores, se ha creado un Registro Internacional (IRoc-GN), que ha permitido identificar a 40 pacientes en Europa y Am\u00e9rica del Norte con COVID-19 y glomerulonefritis. <img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=199&amp;h=135\" alt=\"logo12\" width=\"199\" height=\"135\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/>Se ha recogido\u00a0 informaci\u00f3n sobre su diagn\u00f3stico, tratamiento, complicaciones y resultados. Este grupo de pacientes se ha comparado con un grupo control de 80 pacientes positivos por COVID-19 sin glomerulonefritis. Los pacientes con glomerulonefritis tuvieron mayor mortalidad y lesiones renales m\u00e1s graves que los del grupo control. Por ello, estos pacientes deben ser cuidadosamente monitorizados, sobre todo si presentan niveles bajos de alb\u00famina s\u00e9rica.<\/p>\n<p data-adtags-visited=\"true\">Este estudio, \u201c<a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(20)31281-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring<\/a>\u201d, ha sido publicado en la revista <em>Kidney International<\/em> y uno de sus autores es el nefr\u00f3logo del Hospital 12 de Octubre Enrique Morales.<\/p>\n<p data-adtags-visited=\"true\"><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ante el desconocimiento del impacto del SARS-COV-2 en pacientes con glomerulonefritis inmunomediadas, que a menudo se suelen someter a tratamientos inmunosupresores, se ha creado un Registro Internacional (IRoc-GN), que ha permitido identificar a 40 pacientes en Europa y Am\u00e9rica del Norte con COVID-19 y glomerulonefritis. Se ha recogido\u00a0 informaci\u00f3n sobre \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2020\/11\/16\/glomerulonefritis-covid-19-y-h12o\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-DO","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2468"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=2468"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2468\/revisions"}],"predecessor-version":[{"id":2469,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2468\/revisions\/2469"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=2468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=2468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=2468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}